Floatz logo

Therapeutic Asset Ratings

1,055 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
MEGESTROL ACETATE IMPURITY B
Atypical Endometrial Hyperplasia
Xiaojun ChenP2/3B (57)
MEGESTROL ACETATE IMPURITY B
Infertility Disorder
Xiaojun ChenP2/3B (57)
MEGESTROL ACETATE IMPURITY B
Obesity Disorder
Xiaojun ChenP2/3B (57)
Memantine
Peripheral Neuropathy
Tanta UniversityP2/3B (57)
Memantine Hydrochloride
Amyotrophic Lateral Sclerosis
University of EdinburghP2/3B (57)
Metformin
Atypical Endometrial Hyperplasia
Xiaojun ChenP2/3B (57)
Metformin
Progesterone Resistance
Xiaojun ChenP2/3B (57)
Mexiletine
Kennedy Disease
Masahisa KatsunoP2/3B (57)
Minocycline
Cerebral Infarction
Xiang LuoP2/3B (57)
Minocycline
Hemorrhagic Stroke
Joyce ChenP2/3B (57)
Minocycline
Vascular Occlusion Disorder
Xiang LuoP2/3B (57)
Mitoquinol mesilate
Mitochondrial Disease
Mclean HospitalP2/3B (57)
Mitoquinol mesilate
Schizophrenia
Mclean HospitalP2/3B (57)
MONOCLONAL ANTIBODY BC8
Graft Versus Host Disease
Actinium PharmaceuticalsP2/3B (57)
MONOCLONAL ANTIBODY BC8
Myeloid Leukemia
Actinium PharmaceuticalsP2/3B (57)
Montelukast
Sleep Apnea Syndrome
Great Ormond Street Hospital for Children NHS Foundation TrustP2/3B (57)
N-Acetyl-L-Cysteine
Neoplasm
Fakultas Kedokteran Universitas IndonesiaP2/3B (57)
Naltrexone
Binge Eating Disorder
Yale UniversityP2/3B (57)
Naptumomab Estafenatox
Renal Cell Carcinoma
NeoTX Therapeutics Ltd.P2/3B (57)
Niraparib
Uterine Carcinosarcoma
ARCAGY/ GINECO GROUPP2/3B (57)
Niraparib
Ovarian Carcinosarcoma
ARCAGY/ GINECO GROUPP2/3B (57)
Nogapendekin Alfa
Non-Small Cell Lung Carcinoma
SWOG Cancer Research NetworkP2/3B (57)
Opakalim
Generalized Epilepsy
Biohaven Therapeutics Ltd.P2/3B (57)
Oxygen
Chemotherapy-Induced Neuropathy
Bernardino Clavo, MD, PhDP2/3B (57)
Phenserine
Alzheimer Disease
Helse Stavanger HFP2/3B (57)
Showing 576 to 600 of 1,055 assets
PreviousPage 24 of 43Next